Round led by Lumira Ventures and Roche Venture Fund with new investment from SanofiCHICAGO, June 18, 2026 (GLOBE NEWSWIRE) -- COUR Pharma, a clinical-stage biotechnology company developing ...

Natera, Inc. , a global leader in cell-free DNA and precision medicine, and Aveta Biomics, Inc., a clinical-stage immuno-oncology company advancing first-in-class oral immunotherapies for solid tumors ...

The gut microbiome is not a mere spectator but an active player in colorectal cancer (CRC), driving tumor initiation and ...

Two Danville families are betting big on ostriches as a safe alternative for Alpha-Gal Syndrome sufferers as the tick-borne illness spreads.

People with obesity and type 2 diabetes are at high risk of blood vessel damage. This risk depends not only on the genes a person carries, but also ...

New 2026 research from Finland finds HIF-PHI anemia medications may slow cancer cell growth and block tumor blood vessels ...

A homeschooling center in Manhattan is part of the company’s nationwide expansion. Internal documents reveal its strategy: “Opening date > safety.” In the fall of 2025, top executives from Alpha ...

Alpha School has leased space in this building in Kirkland for its first Seattle-area school. (GeekWire Photo / Todd Bishop) Alpha School, an AI-driven private school chain that promises to teach kids ...

Test time has arrived: the first person has been treated in a highly anticipated gene-therapy trial that aims to coax aged cells to take on a younger identity. The clinical trial is testing an ...

The next step in the youth quest is a technology called chemical reprogramming. The outspoken longevity scientist David Sinclair has been predicting that one day, you’ll go to the doctor and get a ...

Explore why SpaceX is a Strong Buy and Tesla, Inc. a Buy, why a merger could destroy value, and how to allocate 1–5% in your ...